- Introduction to Clinical Research Training
- Medical Education
- United Kingdom Clinical Scholars Research Training
- Vanderbilt Hall
- Financial Aid
- Office of the Registrar
- Campus Planning and Facilities
- Ombuds Office
- Committee on Microbiological Safety
- Human Resources
- HMS Foundation Funds
- Office for Academic and Clinical Affairs
- Joint Committee on the Status of Women
- The Academy
- Global Health Research Core
- Global Clinical Scholars Research Training Program
- HMA Standing Committee on Animals
- Office of Research Compliance
- Global & Community Health
- Harvard Medical School Event Calendar
- Contact @HMS
- Office of Diversity RIA Program
- The Dean's Perspective
- Department of Pathology
- Harvard Mahoney Neuroscience Institute
- OHRA Home
- Office of Research Subject Protection
- Tools and Technology
- Alumni Association
- Cancer Biology & Therapeutics Program
- Celiac Program
- Department of Medicine
- HMS Community Values Initiative
- HMS Information Technology
- HMS TransMed Program
- Introduction to the Practice of American Medicine
- Office of Communications & External Relations
- Master of Medical Sciences In Clinical Investigation
- Office of Global Education
- Portugal Clinical Scholars Research Training Program
- Shenzhen-HMS Initiative in International Education
- South American Clinical Research Training
- test page
- Safety Quality Informatics and Leadership
- Human Resources
- Jobs @ HMS
- Dental Medicine
- Harvard University
- Contact us
The Boston Preservation Alliance has recognized Harvard Medical School’s Gordon Hall Window Restoration Project with a 2013 Boston Preservation Achievement Award.
Gordon Hall is the iconic edifice that defines the Harvard Medical School quadrangle, which were both designed by Shepley Bulfinch in 1904. The Alliance said restoration of the windows and the exterior of the landmark building returned Gordon Hall to the elegance and clarity of its original architectural form, injecting a lasting historic presence into a vibrant modern hub of science, medical discovery, patient care and education.
The restoration returned significant details of the building’s historic exterior while improving energy performance, improving occupant comfort and elevating life safety, the organization said. The work included devising strategies to reduce air infiltration and improve energy efficiency by restoring or replacing all of Gordon Hall’s 100 windows, which include six different types, ranging in scale from multi-story “Union Jack” windows with distinctive Roman patterns, to double-hung sashes.
Executive Dean for Administration, Richard Mills, was instrumental in supporting the project. Richard Shea, associate dean for campus planning and facilities, Kevin Connors, director of engineering and construction, and John Scully, project manager, were part of the team that worked with the Boston Preservation Alliance, along with Kim David Markert from Shepley Bulfinch. Lawrence Sturdivant was the construction manager on the project. The restoration was undertaken by Shawmut Design and Construction and lead by Carl Jay, Shawmut’s director of historic preservation.
The annual preservation awards celebrate people and projects that demonstrate a commitment to Boston’s historic character, including the preservation of the city’s architectural and cultural heritage. The 2013 Boston Preservation Achievement Awards will be presented at a ceremony in October.
Jessica Meir, HMS assistant professor of anaesthesia, has been selected as one of eight members of NASA’s 2013 Astronaut Candidate Class. Meir is a comparative physiologist who studies how different species are adapted to survive in extreme environments, specifically low-oxygen conditions.
Meir has studied emperor penguins and elephant seals in Antarctica, and currently studies how Weddell seals and bar-headed geese live in oxygen-depleted habitats at the Anesthesia Center for Critical Care Research at Massachusetts General Hospital. She has also fostered her love of space by previously studying at the Kennedy Space Center in Florida and the International Space University in Strasbourg, France.
For the next two years, Meir will be training at the Johnson Space Center in Houston, Texas in preparation for her flight into space. NASA Administrator Charles Bolden said these new astronaut candidates will help to lead the first human mission to an asteroid in the 2020s and then eventually to Mars.
Sigall Bell, HMS assistant professor of medicine, Alexander Green, HMS associate professor of medicine, and Jennifer Kesselheim, HMS assistant professor of pediatrics, have been named the recipients of the Arnold P. Gold Foundation Professorship Program.
The professorship honors and supports faculty members who embody the characteristics of a humanistic doctor and awards them with a three-year grant of $150,000 to support projects that further the Gold Foundation’s mission and goals. During the three-year period, each recipient will complete a project that contributes to the knowledge about how to instill the habit of humanistic healthcare.
Bell’s work looks at the effects of institutional culture and the customs that shape communication and moral decision-making in the clinical learning environment on patient safety and humanism.
Green’s work focuses on the “hidden curriculum,” also known as the unofficial learning of both good and bad behaviors and attitudes that occur as students become socialized into organized medicine. More specifically, Green will be conducting a first-of-its-kind study exploring this “hidden curriculum” as it relates to patients with limited English proficiency.
Kesselheim’s work focuses on creating a novel curriculum to address a gap in the humanism training in pediatric fellowships. Her curriculum will also have applicability to other fellowship programs across a range of medical subspecialties.
The Gold Foundation is a non-profit organization dedicated to enhancing the doctor-patient relationship. The program’s purpose is to promote the importance of humanistic medicine and the values of professionalism in medical education. The foundation defines the characteristics of a humanistic doctor as one who demonstrates respect for a patient’s concerns and values while also providing compassionate consideration and care for a patient’s both physical and emotional well-being.
Nancy Rappaport, HMS associate professor of psychiatry, was awarded the Art of Healing Award from Cambridge Health Alliance (CHA). The Art of Healing Award is given to those who transcend boundaries, joyfully embrace humanity and profoundly inspire the healing of body and spirit.
Rappaport, a child and adolescent psychiatrist and director of school-based mental health programs at CHA, oversees mental health services at CHA’s four school-based health centers and treats children who suffer from anxiety, depression and other complex behavioral disorders.
She works closely with local schools to develop innovative strategies to help children with behavioral health issues and provides teachers with tools needed to help recognize children who need help and when to create a plan to help them. The numerous courses she has designed for teachers include psychopharmacology, adolescent development and instructional strategies for disruptive students.
The Massachusetts Attorney General’s Office invited Rappaport to provide testimony on clinical perspectives on how to address bullying. Her research on school violence also drove the Boston City Council to hold a public hearing to explore mental health services in its school system.
Rappaport has published numerous articles in various peer-reviewed journals and also won the Boston Authors Club’s 2010 Julia Ward Howe Prize for her book In Her Wake: A Child Psychiatrist Explores the Mystery of Her Mother’s Suicide. Rappaport also received the American Academy of Child and Adolescent Psychiatry’s Sidney Berman Award for the School-Based Study and Treatment of Learning Disorders and Mental Illness.
Stefanos Kales, HMS associate professor of medicine, was awarded the 2013 Kehoe Award for Excellence in Education and Research in Occupational and Environmental Medicine (OEM) from the American College of Occupational and Environmental Medicine. The lifetime achievement award recognizes an individual for their significant contributions to academic excellence or research in the disciplines of occupational medicine, environmental medicine and environmental health.
Kales was honored with the award for his significant contributions to OEM, including his role as a teacher and researcher to improving worker health as a preeminent authority in cardiopulmonary fitness and firefighting, as well as his contributions in OEM toxicology and occupational sleep medicine and his peer-reviewed publishing.
Kales is the division chief of OEM and medical director of employee and industrial medicine at Cambridge Health Alliance (CHA). He is also the director of the OEM Residency at Harvard School of Public Health (HSPH), where he has developed new approaches to train residents in health and productivity and disability prevention.
J. Thomas Lamont, HMS Charlotte F. and Irving W. Rabb Professor of Medicine and chief of gastroenterology at Beth Israel Deaconess Medical Center, has been awarded the Distinguished Mentor Award from the American Gastroenterological Association (AGA) for his achievements as a mentor.
Lamont was recognized for his excellence and leadership in clinical care, teaching and research and is credited with mentoring current leaders in hepatology, esophageal disease, colon cancer, gastrointestinal infectious diseases and gastrointestinal endoscopy. He provides support to medical students, interns, residents and fellowship trainees.
Lamont has served as councillor-at-large on the AGA Governing Board as well as on many committees, including the Finance and Audit Committees.
The Medical Heritage Library has received the Best Online Resource Award for 2013 from the Archivists and Librarians in the History of the Health Sciences (ALHHS).
The Medical Heritage Library (MHL) is a collaborative effort among several different university libraries that has digitized tens of thousands of medical texts from as far back as the early 1500s, 800,000 of which come from the Center for the History of Medicine at the Countway Library of Medicine. The MHL provides online availability to this large collection of rare texts free-of-charge.
The ALHHS was established for educational purposes to serve the professional interests of librarians, archivists and other specialists engaged in the librarianship of the history of the health sciences.
The HMS Excellence in Mentoring Awards honor faculty members who have made significant contributions to the development of HMS and HSDM faculty, trainees and students. The 2012-2013 Excellence in Mentoring Award winners include:
Young Mentor Award
Ingrid Bassett, assistant professor of medicine
Peter Bex, associate professor of ophthalmology
Benjamin Ebert, associate professor of medicine
Winston Kuo, assistant professor of oral and developmental biology
Galit Lahav, associate professor of systems biology
Samuel Lin, assistant professor of surgery
Biju Parekkadan, assistant professor of surgery
Duane Pinto, associate professor of medicine
Ruth Ann Vleugels, assistant professor of dermatology
A. Clifford Barger Excellence in Mentoring Award
Mercedes Becerra, associate professor of global health and social medicine
Timothy Ferris, associate professor of medicine
Marian Hannan, associate professor of medicine
Sharon Inouye, professor of medicine
Harald Paganetti, professor of radiation oncology
Jose Ricardo Romero, assistant professor of medicine
William Silen Lifetime Achievement in Mentoring Award
Joseph Avruch, professor of medicine
Bruce Ryan Bistrian, professor of medicine
David Clapham, Aldo R. Castaneda Professor of Cardiovascular Research
Russell Phillips, William Applebaum Professor of Medicine
Jane Weeks, professor of medicine
S. Ted Treves, HMS professor of radiology, received the Georg Charles de Hevesy Nuclear Pioneer Award from the Society of Nuclear Medicine and Molecular Imaging (SNMMI) for his contributions to nuclear medicine. SNMMI is an international scientific and medical organization dedicated to raising public awareness about nuclear medicine and molecular imaging.
Every year, SNMMI presents the Georg Charles de Hevesy Nuclear Medicine Pioneer Award to an individual for his or her outstanding contributions to the field of nuclear medicine. Treves’ research focuses on the development and evaluation of diagnostic radionuclide methods, with emphasis in physiologic evaluation and pediatric applications. He has recently been investigating the application of new technologies in order to optimize imaging and reduce the radiation dose to children undergoing nuclear medicine procedures.
Treves founded the first division of nuclear medicine at Boston Children’s Hospital and served at its chief for over 40 years. He is a founding member of the Joint Program in Nuclear Medicine and has served as director of its Residency Training Program. Treves also founded the first Boston Children’s Hospital Small Animal Imaging Laboratory (SAIL).
Treves has been awarded multiple honors for his contributions to nuclear medicine. He is the recipient of the SNMMI George V. Taplin Award, the SNMMI New England Chapter Holman-Kaplan Lectureship Award and the first SNMMI Pediatric Imaging Council Conway-Treves Senior Investigator Award, which is named in his honor. He also was named Mentor of the Year from the American College of Nuclear Medicine.
The HMS 2013 Dean’s Community Service Award is given to honor individuals at HMS and HSDM who have made outstanding personal contributions to the local, national or international community. HMS contributes $1,000 to the organization that each Community Service Award recipient has worked to support. There have been 92 awardees to date who include 37 faculty members, 10 of whom have earned Lifetime Achievement awards, 20 trainees, 19 students and16 staff members. The 2013 Community Service winners include:
Lifetime Achievement Award
Nancy Oriol, HMS dean for students and associate professor of anaesthesia, The Family Van
Yvonne Gomez-Carrion, assistant professor of obstetrics, gynecology and reproductive biology, Concerned Black Men of Massachusetts
Thanh-Nga Tran, MD, instructor in dermatology, Vietnam Vascular Anomalies Center
Cheri Blauwe, clinical fellow in physical medicine and rehabilitation, Spaulding Adaptive Sports Centers
Benjamin Robbins, HMS 2014, SALAMA: Tanzania
Amanda Nichols, staff assistant III, systems biology, The National MS Society
Philip Snell, research assistant III protein engineering, PEER Servants
Five members of the Harvard Medical School faculty have been awarded the Harvard Medical School Academy Fellowship in Medical Education for the 2013-2014 academic year. This endowed program seeks to enhance and develop the fellows’ analytical skills as medical education researchers as well as their teaching skills as medical educators.
The faculty members are selected based on whether the proposed projects will contribute to the education of HMS students through curriculum innovation, outcomes assessment, faculty development or enrichment opportunities. Each selected Academy Fellow completes a fellowship project over the course of the academic year.
“Each of the fellows’ projects has the potential to make a real impact on the continuous improvement of teaching and learning at HMS and our affiliated hospitals,” said Edward Hundert, director of the HMS Academy Center for Teaching and Learning and senior lecturer in medical ethics in the Department of Global Health and Social Medicine.
The 2013-2014 Academy Fellows in Medical Education include:
Curtis Prout Fellows of the Academy
Instructor in Psychiatry
Department of Psychiatry
Instructor in Medicine
Department of Medicine
Brigham and Women’s Hospital
Instructor in Medicine
Department of Medicine
Cambridge Health Alliance
Morgan-Zinsser Fellows of the Academy
Instructor in Pathology
Department of Pathology
Brigham and Women’s Hospital
Instructor in Medicine
Department of Emergency Medicine
Brigham and Women’s Hospital
Academy Fellowships are made possible through contributions to the Morgan-Zinsser, Curtis Prout, and Susan and James Jackson Academy Fellowship Funds.
Jill Kasper, HMS instructor in pediatrics at Cambridge Health Alliance (CHA), received the 2013 Primary Care Award for Teaching and Mentoring, presented by Partners HealthCare. The award recognizes those committed to mentoring the next generation of primary care clinicians, specifically younger clinicians, as they progress along their career paths.
Kasper’s accomplishments include her role with the HMS Cambridge Integrated Clerkship, where she has served as a preceptor, site coordinator, and pediatric liaison. Kasper was a fellow in medical education at Mount Auburn Hospital in Cambridge and also received the Medical Student Teaching Award from Mass General Hospital for Children.
Partners HealthCare is a non-profit organization with an integrated health care system that provides patients with primary care and specialty physicians, community hospitals, the two founding academic medical centers, specialty facilities, community health centers and other health-related entities.
Sara Beese-Sims, HMS postdoctoral research fellow, has been selected by the Genetics Society of America (GSA) as a recipient of the fall 2013 DeLill Nasser Award for Professional Development in Genetics. Beese-Sims will be focusing on her research entitled Epigenetics: Mechanisms and Implications.
The award provides a $1,000 travel grant for selected researchers to attend any national or international meeting, conference or laboratory course that will enhance their career.
Nearly 100 graduate students and postdoctoral researchers have received similar funding to help further their career goals and enhance their education through travel. The program is supported by GSA and by charitable donations from members of the genetics community. GSA selects graduate students and postdoctoral researchers to receive DeLill Nasser Awards twice a year. GSA established the award in 2001 to honor DeLill Nasser, for whom the award is named.
H. Stephen Leff, HMS associate clinical professor of psychology at Cambridge Health Alliance, has received the Carl Taube Award from the American Public Health Association. The award is given to scholars who have made important contributions to the mental health field.
Leff’s work focuses on resource allocation and planning models for state and local mental health agencies, needs assessment, the measurement of cultural competency, fidelity, workforce development and evidence-based practices.
In 1990, the award was named after Carl Taube, a long-time staff member of the NIMH, as a way to honor the many contributions he made to mental health policy and research.
Four members of the Harvard Medical School faculty were recently elected to the National Academy of Sciences (NAS). They were among 84 new members and 21 foreign associates chosen from 14 countries in recognition of their distinguished and continuing achievements in original research.
Members include some of the world’s most accomplished scientists, writers, scholars, artists and civic, corporate and philanthropic leaders. Scientists are elected into membership by their peers based upon their contributions to research.
The four HMS inductees include:
Mitzi Kuroda, professor of genetics. Kuroda’s research focuses on Chromatin organization, non-coding RNAs and epigenetic gene regulation;
Norbert Perrimon, James Stillman Professor of Developmental Biology. Perrimon’s research includes using the fruit fly, Drosophila, to understand the mechanisms by which cells and tissues communicate to coordinate the formation of specific structures during development and to maintain homeostasis;
Gerhard Wagner, Elkan Rogers Blout Professor of Biological Chemistry and Molecular Pharmacology. Wagner’s research is concerned with structures of proteins and protein complexes, as well as biomarker identification and measuring metabolite levels for characterizing and monitoring human disease;
Fred Winston, John Emory Andrus Professor of Genetics. Winston’s research focuses on understanding eukaryotic gene expression and chromatin structure by using the yeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe.
Pardis Sabeti, HMS assistant professor of immunology and infectious disease, has been selected as a 2013 National Geographic Emerging Explorer. National Geographic’s Emerging Explorers Program recognizes and supports gifted and inspiring adventurers, scientists and innovators who are at the forefront of discovery, adventure and global problem solving while still early in their careers. A $10,000 award is given to each recipient to assist with their future research.
Sabeti explores medical and evolutionary genetics to better understand the origins of our acquired traits as well as to help prevent the spread of infectious diseases. She also uses algorithms that she has invented to help crack genetic codes in an effort to learn how infectious diseases adapt, spread and may one day be prevented.
Sabeti has characterized malaria’s enormous genetic diversity, which allows it to rapidly adapt and evade treatment, in order to better understand its drug resistance, help eliminate disease epicenters, track its transmission and ultimately treat the disease with more effective drug strategies. Sabeti is also conducting research on the Lassa virus and shedding new light on typhoid.
Sabeti joins a roboticist, an astrobiologist, a glaciologist, a planetary geologist, an artist and an entrepreneur as one of 17 young professionals from around the world who have been selected as Emerging Explorers.
Two members of the Harvard Medical School faculty have been awarded the 2013 Wellcome Career Award for Medical Scientists. The award provides $700,000 over five-years to help physician scientists obtain a faculty position and continue their research.
The two HMS awardees are:
Andrew Eugene Hermann Elia, instructor in radiation oncology at Massachusetts General Hospital. The title of his project is “Proteomic Analysis of Ubiquitination and Protein Stability in the DNA Damage Response.”
Alex Kentsis, instructor in pediatrics at Boston Children’s Hospital. The title of his project is “Tumorigenesis by Endogenous DNA Transposons in Human Cancer.”
The Burroughs Wellcome Fund is an independent private foundation that is dedicated to advancing the biomedical sciences by supporting research and other scientific and educational activities. Since its creation in 2006, the program has funded 72 researchers, 69 of whom are still conducting research.
Shekinah Elmore and David Duong are the two Harvard Medical School students honored this spring with Fulbright grants from the Fulbright U.S. Student Program.
Fulbright grant recipients are selected on the basis of academic or professional achievement, as well as demonstrated leadership potential in their fields. The academic fields include the social sciences, humanities and the sciences.
The Fulbright Program operates in more than 155 countries worldwide. Sponsored by the U.S. government, it is one of the country’s flagship international educational exchange programs, designed to increase mutual understanding between the people of the U.S. and other countries.
The Fulbright program provides fellowships for graduating college seniors, graduate students, young professionals and artists from the U.S., allowing study abroad for one academic year. It offers the opportunity to study, teach and conduct research, exchange ideas and contribute to solutions around shared international concerns.
Rafael Campo, HMS associate professor of medicine at Beth Israel Deaconess Medical Center, recently received a Hippocrates Prize for Poetry and Medicine. The Hippocrates Prize winners where announced at the International Symposium on Poetry and Medicine in London on May 18, 2013.
The Hippocrates Prize is one of the most valuable international poetry prizes, with a yearly purse of £15000. For his first prize award Campo received £5000.
"The Fellowship of Postgraduate Medicine is delighted with the increasing success of the Hippocrates Open Awards in reaching out globally to poets, health professionals and the public,” said Donald Singer, Hippocrates Prize co-founder and president of the Fellowship of Postgraduate Medicine, the major patron of the Hippocrates Initiative.
"This year's winner Rafael Campo eloquently shows the power of poetry to help both health professionals and patients to engage with and learn from each other under the most testing of medical and personal challenges".
The awards symposium considered themes including poetry as therapy to help in recovery from stroke, poetry in health professional training, the impact of illness on the poet, and the history of poetry and medicine.
Stuart Orkin, David G. Nathan Professor of Pediatrics at Boston Children’s Hospital, was one of 18 individuals recognized by the National Academy of Sciences for outstanding scientific achievements in a wide range of fields spanning the physical, biological, and social sciences.
Orkin was awarded the Jessie Stevenson Kovalenko Medal for important contributions to the medical sciences for his pioneering achievements in defining the molecular basis of blood disorders and the mechanisms governing the development of blood stem cells and individual blood lineages. His work has significantly advanced the understanding of human hematologic diseases and revealed new strategies to prevent and manage these disorders.
The award, which consists of a medal and a prize of $25,000, was established through the Jessie Stevenson Kovalenko Fund.
Boston Children’s Hospital and Harvard Medical School announced they have received approximately $9 million in grants from The Massachusetts Life Sciences Center. The funds are being allocated to Boston Children’s Hospital and HMS in order to renovate their research labs.
HMS received a $5 million grant that will be used to create a Laboratory of Systems Pharmacology that will serve as a multidisciplinary incubator to provide better clinical trial information in the drug development process.
A $4 million grant was also awarded to Boston Children’s Hospital to help establish the Children’s Center for Cell Therapy and to support lab renovations that will allow additional cell culturing facilities. It will also help to create a robotics area designed to perform highly specialized chemical screening on stem cells.
In total, the center announced more than $9.35 million in grants to support life-sciences-related capital projects in the Greater Boston area.
Through the center, Massachusetts is investing $1 billion over a 10-year period to support the growth of the state’s life sciences industries. These investments are being made under the Massachusetts Life Sciences Initiative, placed into law by Gov. Deval Patrick in 2008.
Don Ingber, Judah Folkman Professor of Vascular Biology in the Department of Pathology at Harvard Medical School and founding director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, received the NC3Rs 3Rs Prize from the UK’s National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) for his innovative Lung-on-a-Chip, a microdevice lined by human cells that recapitulates complex functions of the living lung.
“This award helps to validate this radical new approach on the global stage, and to strengthen our resolve to work with government agencies and pharmaceutical companies that have been supporting our work to pursue this alternative approach to animal testing,” said Ingber.
The lung-on-a-chip offers a new in vitro approach to drug screening by mimicking the complicated mechanical and biochemical behaviors of a human lung. It is a small device the size of a memory stick composed of a clear, flexible polymer that contains hollow channels fabricated using computer microchip manufacturing techniques.
Ingber’s team used the lung-on-a-chip to mimic pulmonary edema, or fluid on the lungs, a complex human disease. The researchers closely mimicked a drug toxicity that produces pulmonary edema in humans, identified potential new therapies to prevent this life-threatening condition, and revealed new insights about the disease, specifically demonstrating on the chip that the physiological breathing motion of the lungs exacerbates drug toxicity-induced edema. They also studied the disease process in real time, precisely tracking fluid flow and clot formation, which cannot easily be done using an animal model.
Ingber and his team received the award at a ceremony in London on February 26 and will receive a monetary award equivalent to about $30,000, which will be used to support continued research and collaboration around the on-chip technology.
Ingber’s lung-on-a-chip research has been funded by the National Institutes of Health, the Food and Drug Administration and the Defense Advanced Research Projects Agency, which is also supporting his work to integrate the lung-on-a-chip with more than nine other organ chips to create a “human body on-a-chip” that mimics whole body physiology.
Anne Goldfeld, HMS professor of medicine at Brigham and Women's Hospital and senior investigator in the Program in Cellular and Molecular Medicine at Boston Children's Hospital received the Dr. Jean Mayer Global Citizenship Award (http://www.tuftsgloballeadership.org/program/dr-jean-mayer-award) from the Institute of Global Leadership from Tufts University on February 24th. Goldfeld was presented with the award at Tuft’s Institute for Global Leadership's annual symposium, held at the Fletcher School of Law and Diplomacy at Tufts, where she was a featured speaker. The award was given to her "In recognition of a lifetime of passionate thinking and caring to ensure the vitality and integrity of vulnerable peoples."
The Dr. Jean Mayer Global Citizenship Award was established in 1993 to honor the work and life of Jean Mayer, president and chancellor of Tufts University from 1976-93, and it is given annually to individuals whose moral courage, personal integrity, and passion for scholarship resonated his dictum that: "Scholarship, research and teaching must be dedicated to solving the most pressing problems facing the world." Past recipients have included Nobel Laureates Amartya Sen, Desmond Tutu and Mohammed Yunus.
JoAnn Manson, the Michael and Lee Bell Professor of Women’s Health at Brigham and Women’s Hospital, will receive the Bernadine Healy Award for Visionary Leadership in Women’s Health at Women’s Health 2013: The 21st Annual Congress in Washington, DC.
Manson is chief of the Division of Preventive Medicine at Brigham and Women’s Hospital. She has led several major research studies addressing prevention of heart disease, diabetes and cancer in women, including the VITamin D and OmegA-3 TriaL (VITAL trial), the Women’s Health Initiative Clinical Center, the Women’s Antioxidant and Folic Acid Cardiovascular Study, the cardiovascular component of the Nurses’ Health Study and the Kronos Early Estrogen Prevention Study. Manson is a member of the Institute of Medicine and recently served as president of the North American Menopause Society. She has published more than 700 articles in the medical literature and several books.
Manson will present a lecture on “New Findings from the Kronos Early Estrogen Prevention Study” during the congress. The congress is presented by the Academy of Women’s Health, Journal of Women’s Health and the Virginia Commonwealth University Institute of Women’s Health.
Terence Keane, HMS lecturer on psychiatry at the VA Boston Healthcare System, is a recipient of the Distinguished Scientific Contributions to Clinical Psychology Award—the highest award for science given by the Society of Clinical Psychology of the American Psychological Association.
Keane, the associate chief of staff for research at the VA Boston, is recognized as a world leader in the field of traumatic stress. He developed many of the most widely used post-traumatic stress disorder assessment measures and is considered an authority on the cognitive-behavioral treatment of PTSD. Keane was co-chair of the National Institute of Mental Health Consensus Conference that established national standards for the diagnosis and assessment of PTSD.
Keane’s scientific work on the recognition, psychopathology, assessment and effective treatment of trauma-related conditions and disorders has moved the field of traumatic stress into the mainstream of clinical psychology. His research has been continuously funded for 29 years and he has published more than 230 books, papers and chapters. He is a past president of International Society for Traumatic Stress Studies (ISTSS) and a fellow of the American Psychological Association and the American Psychological Society.
He has received many awards, including a Fulbright Scholarship, Binghamton University's Edward Weisband Distinguished Alumnus Award, the Association for Advancement of Behavior Therapy's Outstanding Researcher Award, the Robert J. Laufer Outstanding Scientific Achievement Award and the Lifetime Achievement Award from the ISTSS.
Robert Langer, HMS senior lecturer on surgery at Boston Children's Hospital, was one of 11 inventors awarded the National Medal of Technology and Innovation. Langer also won the National Award of Science in 2006, one of only three Americans to have won both the National Medal of Science and the National Medal of Technology and Innovation. He is a professor at the Massachusetts Institute of Technology and member of the faculty of the Harvard-MIT Division of Health Sciences and Technology.
Langer is renowned for his revolutionary work on new and different ways to administer drugs to patients. A biomedical engineer who focuses on biomaterials, Langer has developed a variety of novel drug-delivery systems based on polymers, including materials that can release drugs continuously over a prolonged period of time. In the field of nanotechnology, he is developing particles that precisely target disease sites, including tumors.
The National Medal of Technology and Innovation was established in 1980 and is administered for the White House by the U.S. Department of Commerce’s Patent and Trademark Office. The award recognizes those who have made lasting contributions to America’s competitiveness and quality of life and helped strengthen the nation’s technological workforce. Nominees are selected by a distinguished independent committee representing the private and public sectors.
Elizabeth Rider, HMS assistant professor of pediatrics at Boston Children's Hospital, was selected by the National Academies of Practice to receive the prestigious Nicholas Andrew Cummings Award.
Rider is the Director of Academic Programs for the Institute for Professionalism and Ethical Practice, Boston Children’s Hospital, and Director of Programs for Communication Skills at the Stoeckle Center for Primary Care Innovation at Massachusetts General Hospital. She is co-chair of the Medicine Academy and a senior fellow of the National Academies of Practice.
The Nicholas Andrews Cummings Award is given annually to an individual who has made extraordinary and enduring contributions nationally to interprofessional healthcare education and practice. Rider was recognized for her many outstanding contributions to interprofessional healthcare and education at the local, national, and international levels, and for her distinguished career as a physician and educator. The Cummings Award was presented to Rider at National Academies of Practice’s annual Membership Induction Banquet in Washington, D.C.
Kun Ping Lu, HMS professor of medicine, was recently named a fellow of the American Association for the Advancement of Science (AAAS).
Lu was elected as an AAAS fellow for his contributions to signal transduction mechanisms through controlling prolyl isomerization of key molecules in cell cycle control, tumor formation, and onset of neurodegenerative diseases such as Alzheimer’s. Currently, Lu is a faculty member in Beth Israel Deaconess Medical Center’s Division of Hematology/Oncology and Cancer Center.
Lu is among 702 members to be recognized this year for his efforts to advance science. Lu and other fellows will be honored during the 2013 AAAS members meeting in February.
Schepens Eye Institute, Massachusetts Eye and Ear has named Patricia D’Amore as director of research at Schepens Eye Research Institute. D’Amore is professor of ophthalmology and pathology at Harvard Medical School. As director of eesearch, she will serve as the senior leader at Schepens and as a member of the Massachusetts Eye and Ear research leadership team.
D’Amore’s selection follows a rigorous, eight-month effort by an HMS-appointed search committee to identify a highly accomplished academic and scientific leader who has achieved significant success in advancing the field of vision science.
D’Amore has distinguished herself as an astute investigator, dedicated teacher, and gifted administrator who brings nearly three decades of scientific accomplishment and leadership to her new role. Her responsibilities will include shaping Schepens’ research goals and objectives, crafting the Institute’s scientific policy development and priorities, mentoring faculty and overseeing faculty career development and promotion, and building collaborative relationships between Harvard research groups and clinical areas, and with industry and academia, among other critical duties.
From 2001 until 2011, D’Amore served as co-chair of the Program in Development in Angiogenesis, Invasion & Metastasis at the Dana-Farber/Harvard Cancer Center. At Schepens, she was appointed associate director of research in 2002, and assumed the role of co-director of research in 2009. More recently, she was named co-director of the AMD Center of Excellence at HMS. She founded the Boston Angiogenesis Meeting, now in its 14th year, as a forum for presenting new findings and promoting collaboration, understanding, and advancement in angiogenesis research. More recently, she co-directed the highly successful biennial Age-related Macular Degeneration (AMD) Symposium, an international forum that draws an elite group of clinicians and researchers to advance discussion on a wide array of AMD topics. For her efforts in training future leaders in research, she was honored in 2006 with the A. Clifford Barger Excellence in Mentoring Award.
As an internationally recognized expert in vascular growth and development, D’Amore’s investigations have led to a deeper understanding of the molecular basis of eye diseases, and helped form the foundations of vascular targeting therapies. Her work uncovered important physiological roles of vascular growth factors, and yielded crucial insight into the safe use of antiangiogenic therapies. She contributed to the development of vascular-targeting therapies (VEGF inhibitors) - and today, these therapies are used to treat various cancers and retinal disease, including age-related macular degeneration and diabetic retinopathy, and have helped millions of people avoid blindness.
She has received multiple recognitions for her scientific and academic contributions, including a Senior Scientific Investigator Award from Research to Prevent Blindness (2006), Gold Fellow recognition by the Association for Research in Vision and Ophthalmology (2009), and the 2012 Rous-Whipple Award from the American Society of Investigative Pathology.
Joan Reede, Harvard Medical School (HMS) associate professor of medicine and dean for diversity and community partnership, and Nancy Oriol, HMS associate professor of anesthesia, recently became two of 22 distinguished professors honored with the Beckman Trust Award. The award recognizes current or former professors, teachers, or instructors from universities around the United States who have inspired students to make significant contributions to society. Each of the recipients will receive a $25,000, one-time cash prize from the Elizabeth Hurlock Beckman Award Trust.The Beckman Trust Award was first introduced in 2008. Awards are based on a nomination application process. Reede was nominated by her former Harvard School of Public Health student, Nawal Nour, associate professor of obstetrics, gynecology and reproductive biology at HMS. Oriol was nominated by Jeffrey Flier, HMS dean of the faculty of medicine, and Cheryl Dorsey, a former student.
Lynn Eckert, senior lecturer in pediatrics at Harvard Medical School, was selected by the Board of the Foundation for the History of Women in Medicine (FHWIM) as the 2012 recipient of the Alma Dea Morani, MD Renaissance Woman Award.
Eckhert is currently serving as interim dean of the Lebanese American University in Beirut, and director of academic programs at Partners Healthcare International in Boston. She has previously served as chairman of the Board of Trustees of the Educational Commission for Foreign Medical Graduates, and is a past president of the Association of Teachers of Preventative Medicine. She is currently a member of the Board of Directors of the Massachusetts Academy of Family Physicians.
Since 2000, the FHWIM has presented the Alma Dea Morani Award, which honors an outstanding woman physician or scientist in North America who has furthered the practice and understanding of medicine and has made significant contributions outside of medicine.
FHWIM is an internationally recognized organization whose mission is to promote the history of women in medicine and the medical sciences on a national and international level.
John Mekalanos, the Adele Lehman Professor of Microbiology and Molecular Genetics at Harvard Medical School, is among four inaugural winners of the Sanofi-Institut Pasteur Award.
The major new award honors Mekalanos for his multiple discoveries on the complex and multifaceted mechanisms of cholera pathogenesis. The award carries a prize of €120,000 ($155,500). Mekalanos, the head of the Department of Microbiology and Immunobiology at HMS, delivered an award lecture Nov. 13 at the Institut Pasteur in Paris.
James Perrin, professor of pediatrics at Harvard Medical School and director of general pediatrics at the MassGeneral Hospital for Children, will become president of the American Academy of Pediatrics (AAP) for a one-year term in 2014. He accepted the role of president-elect at the group’s New Orleans conference in October.
Perrin is the founder and director of the Massachusetts General Hospital Center for Child and Adolescent Health Policy. He also leads the Clinical Coordinating Center of Autism Speaks Autism Treatment Network (ATN) and Autism Speaks ATN’s Autism Intervention Research Network on Physical Health. He has served in various roles with the AAP, including leading groups on mental health, genetics and developmental disabilities.
Benjamin Warf, associate professor of surgery at Harvard Medical School and associate in neurosurgery at Boston Children’s Hospital, was recently named a 2012 MacArthur Foundation Fellow, one of four Boston-area recipients of the “genius grant.” The award comes with a $500,000 stipend to individuals who have shown originality and dedication in their creative pursuits.
Warf, director of neonatal and congenital anomaly neurosurgery at Children’s, developed an effective method for treating hydrocephalus, an excess of water on the brain, in his patients in Uganda by cauterizing tissues in the brain to slow the production of fluid and make small openings in the base of the brain to allow for fluid to drain into the cavity around it.
Warf and his colleagues are partnering with a hospital and medical school in western Uganda to follow mothers and babies from birth to six months of age to learn more about those who develop hydrocephalus. He has trained 20 neurosurgeons, mainly in Africa and hopes that the study data will provide a more global look at the condition and the various pathogens that potentially cause it. The MacArthur award will further that goal.
The U.S. Department of Health and Human Services has recognized Boston Children’s Hospital’s Kidney Transplant Program as a national leader in its field. The program received a Silver Level Award, the only program in New England—adult or pediatric—to be so recognized, at a Medal of Honor Ceremony held in October. Boston Children’s nephrology department is the only program in New England dedicated to caring for young children and teens.
Measurements of a program’s performance in key areas were evaluated, including how quickly patients received transplants after being placed on a waitlist, post-transplant graft survival rates and patient mortality rates while waiting for an organ to become available. Over 700 transplant programs were evaluated, with only 44 given the Silver Level Award.
Lynn Eckhert, senior lecturer in pediatrics at Harvard Medical School, was recently selected by the Board of the Foundation for the History of Women in Medicine (FHWIM) as the 2012 recipient of the Alma Dea Morani, MD Renaissance Woman Award.
Eckhert is currently serving as interim dean of the Lebanese American University in Beirut and director of academic programs at Partners Harvard Medical International in Boston. She has previously served as chairman of the Board of Trustees of the Educational Commission for Foreign Medical Graduates, and is a past president of the Association of Teachers of Preventive Medicine. She is currently a member of the Board of Directors of the Massachusetts Academy of Family Physicians.
Since 2000, the FHWIM has presented the Alma Dea Morani Award, which honors an outstanding woman physician or scientist in North America who has furthered the practice and understanding of medicine and has made significant contributions outside of medicine.
Joan Reede, dean for diversity and community partnership and associate professor of medicine at Harvard Medical School, was recently awarded by Wells Fargo the Elizabeth Hurlock Beckman Award. Recipients of the award receive $25,000 as a one-time grant to be used at their sole discretion. The Beckman Award was created to benefit teachers who have inspired their former students to make a difference in their communities.
Reede, the School’s first dean for diversity and community partnership, works to recruit and prepare minority students for jobs in the biomedical professions and to promote better health care policies for the benefit of minority populations.
Curtis Cetrulo Jr., instructor in surgery at Harvard Medical School, recently led the team in the completion of a hand transplant, the first procedure of its kind at Massachusetts General Hospital.
Hand transplants, though still relatively rare, have proven to restore the recipients’ ability to perform many routine daily tasks. In 2011, Mass General announced that it was launching a hand transplant program, with the goal of eventually developing a way to replace limbs without subjecting the recipient to a lifetime of anti-rejection drugs.
Physicians from Brigham and Women’s, Beth Israel Deaconess Medical Center, and Boston Children’s Hospital were involved in the procedure, participating in planning meetings and observing or assisting in the operation.
Mary-Jo Delvecchio Good, professor of global health and social medicine at Harvard Medical School, was recently selected by the Foreign Affairs Office of the Shanghai Municipal Government as the recipient of the Silver Magnolia Award. Good was nominated by alumni of the Fogarty Center-sponsored training program for her contributions to educating young Chinese leaders and researchers in the field of mental health and for supporting young women to become leaders in the field of mental health.
Good was among 58 individuals, including four women, from 17 countries who received the Silver Magnolia Award this year. Since 1989, the Shanghai Municipal People’s Government has conferred the award in recognition of outstanding contributions of foreigners to Shanghai’s economic, social, and cultural development.
Adam Bass, HMS assistant professor of medicine at Dana-Farber Cancer Institute, received a 2012 Doris Duke Clinical Scientist Development Award. Bass’ project title is “Targeting SOX2-Driven Squamous Cell Carcinoma.” The award provides funding for physician-scientists who are establishing their own research teams, enabling them to secure 75 percent of their professional time for clinical research.
Four members of the HMS community received Burroughs Wellcome Fund awards. The fund is an independent private foundation dedicated to advancing the biomedical sciences by supporting research and other scientific and educational activities.
Jonathan Kagan, HMS assistant professor of pediatrics at Boston Children's Hospital, received a Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease award. The award is intended to give recipients the freedom and flexibility to pursue high-risk projects and new avenues of inquiry. Kagan’s project on novel approaches for studying RIG-I–like receptor mediated antiviral immunity.
Three HMS faculty members received Burroughs Wellcome Career Awards for Medical Scientists. These awards are given to help physician-scientists obtain a faculty position and continue conducting research.
Benjamin Gewurz, HMS instructor in medicine at Brigham and Women's Hospital, received the award for his project on identification of novel NFkB pathway components important for lymphomagenesis.
David Ting, HMS instructor in medicine at Massachusetts General Hospital, received the award for his project on characterization of noncoding RNAs in pancreatic adenocarcinoma.
Hao Zhu, HMS instructor in medicine at Dana-Farber Cancer Institute, received the award for his project on investigating the Lin28/let-7 pathway in mouse models of liver cancer and regeneration.
Research to Prevent Blindness (RPB) awarded three grants to the HMS community. This organization is the leading volunteer health organization supporting eye research directed at the prevention, treatment or eradication of all diseases that threaten vision.
Massachusetts Eye and Ear and the HMS Department of Ophthalmology received a grant from RPB. This grant will support research into the causes, treatment and prevention of blinding diseases. Joan Miller, the Henry Willard Williams Professor of Ophthalmology and head of the Department of Ophthalmology at Mass Eye and Ear will direct the research.
Joseph Ciolino, HMS instructor in ophthalmology at Mass Eye and Ear, received a Research to Prevent Blindness Career Development Award. Ciolino’s research interests include translational projects such as keratoprosthesis and ocular drug delivery.
Tatjana Jakobs, HMS assistant professor of ophthalmology at Mass Eye and Ear, received the Dolly Green Scholar Award. The award was established to help physician-scientists pursue promising scientific leads and opportunities for which other funds are not readily available. Jakobs’ research focuses on the causes of optic nerve death in glaucoma.
Three members of the HMS community receive Damon Runyon Cancer Research Foundation awards
Li He, HMS research fellow in genetics, received a Damon Runyon Fellows Award. This three-year award is presented to outstanding postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators across the country. The award encourages the nation's most promising young scientists to pursue careers in cancer research by providing them with independent funding to work on innovative projects.
He, working in the lab of Norbert Perrimon, HMS professor of genetics, is studying how organ size and quality are controlled. Cell competition is a phenomenon by which cells possessing unequal "fitness" compete with each other during tissue growth or regeneration. Activation of apoptosis (programmed cell death) in the "loser" cells in turn triggers compensatory proliferation of the "winners." This process can eliminate tumor cells at an early stage; however, itå may also be hijacked by cancer cells to invade healthy tissue. He’s goal is to generate a comprehensive understanding of signals that govern this process.
Laura Pontano Vaites, research fellow in cell biology, received a Damon Runyon Fellows Award. Pontano Vailes works in the lab of J. Wade Harper, Bert and Natalie Vallee Professor of Molecular Pathology in the Department of Cell Biology,where she focuses on the autophagy pathway, a critical regulatory network that allows cells to recycle cellular components to survive nutrient-depleted conditions. Deregulation of autophagy leads to diseases, including cancer. The proposed work will provide detailed insight into the dynamics and organization of complexes required for autophagy and how this organization may be disrupted in cancer.
Ryan Corcoran, HMS instructor in medicine at Massachusetts General Hospital, has received a Damon Runyon Clinical Investigators Award. This prestigious three-year award is given to outstanding early-career physician-scientists conducting patient-oriented cancer research at major research centers under the mentorship of the nation’s leading scientists and clinicians. Corcoran’s project title is “Defining novel targeted therapy combination strategies for BRAV V600 mutant colorectal cancer.”
Two faculty members will be recognized as distinguished scientists at the American Heart Association Scientific Sessions 2012 in November.
Sharon-Lise Normand is HMS professor of health care policy and HSPH professor of biostatistics. Normand’s primary area of interest is statistical methods for health services research, primarily using Bayesian approaches to problem solving, including assessment of quality of care, methods for causal inference, provider profiling, meta-analysis, circulatory system devices and latent variable modeling. She has developed a long line of research on methods for the analysis of patterns of treatment and quality of care for patients with cardiovascular disease in particular. Normand has also developed analytical approaches for comparing providers using outcomes and process-based measures. Normand is being recognized as a distinguished scientist because she is among a handful of individuals who have a major influence on how the quality and utilization of health care in the United States is measured, reported and delivered.
Warren Zapol is HMS Reginald Jenney Professor of Anaesthesia at Massachusetts General Hospital and a member of the affiliated faculty of the Harvard-MIT Division of Health Sciences and Technology.Zapol’s scientific vision led to rapid translation of findings in experimental animal models to benefit patients with a broad spectrum of cardiovascular diseases. Zapol began his research career with post-doctoral training at NIH from 1967 to 1970. During this time he made pivotal contributions to the development of a novel membrane oxygenator that were quickly translated to the treatment of babies and adults with respiratory failure. Over the past 20 years, his laboratory has focused on the physiological and pathophysiological roles of nitric oxide. Based on his lab's pioneering studies, inhaled nitric oxide is now used to treat approximately 30,000 patients per year in the U.S. to dilate the pulmonary circulatory system and to augment arterial oxygenation. For many hypoxic infants and for children post-heart surgery, this inhaled therapy is lifesaving. Zapol is being recognized as a distinguished scientist because his seminal observations are nothing short of groundbreaking, and he represents a role model for every clinical scientist.
Bradley Hyman, the John B. Penney Jr. Professor of Neurology at HMS and the director of the Massachusetts Alzheimer’s Disease Research Center at Massachusetts General Hospital, received the Henry Wisniewski Lifetime Achievement Award. Hyman’s clinical career is devoted to the care of patients with dementia. His laboratory is pursuing research in Alzheimer's disease (AD) and other neurodegenerative diseases with a goal of understanding the neuropathophysiologic and genetic factors that underlie dementia. His laboratory is developing methods to examine clinicopathological correlates and biomarkers in AD, as well as animal and cell models to explore the natural history of the diseases. A recent focus has been the use of advanced microscopy methods—including multiphoton microscopy for in vivo imaging of plaques, tangles and synuclein aggregates, as well as FRET methods to detect protein-protein interactions and protein conformation.
Bruce Chabner, HMS professor of medicine and the director of the clinical center at Massachusetts General Hospital, was awarded a doctorate of the university from Queen’s University in Belfast, Northern Ireland for services to science and medicine. He is an internationally renowned medical oncologist and cancer pharmacologist who has devoted his medical career to clinical research and the improvement of patient care.
Delivering the citation to Chabner, Patrick Johnston, dean of the School of Medicine, Dentistry and Biomedical Sciences at Queen’s, said “One of the major features of Dr. Chabner’s career has been his focus on the improvement of treatments for patients, which remains his major goal. Both his clinical and research work have led to significant advances in patient treatment and improvements in the quality of care provided to patients during both his time at the National Cancer Institute and, more recently, at Harvard Medical School. He has been an inspiration to many leading U.S. and international oncologists and cancer specialists who have gone on to implement his legacy of quality cancer care throughout the world.”
David Osser, HMS associate professor of psychiatry at the Veterans Affairs Boston Healthcare System Department of Psychiatry, was the recipient of the 2012 American Psychiatric Association and the American Association of Chairs of Departments of Psychiatry Research Mentorship Award. The award was given in recognition of substantial and formative contributions to the mentoring of students and residents throughout a distinguished career in psychiatric research.
Eliot Berson, HMS William F. Chatlos Professor of Ophthalmology at Massachusetts Eye and Ear, recently received a Foundation Fighting Blindness Visionary Award. The award was presented to Berson for his important role in research to advance the understanding of potentially blinding diseases and for the development of the first treatment for retinitis pigmentosa.
Berson has served as director of Mass. Eye and Ear Electroretinography Service since 1970, and as director of the Berman-Gund Laboratory for the Study of Retinal Degenerations at Mass. Eye and Ear since 1974.
Frederick Rowland, medical director of Long-Term Care and Clinical Operations at Hebrew Rehabilitation Center in Boston and at NewBridge on the Charles in Dedham and an HMS instructor in medicine at Beth Israel Deaconess Medical Center, was recognized as Mentor of the Year by the Harvard Medical School Multi-Campus Fellowship in Geriatric Medicine program. Rowland was honored for having the greatest positive impact on the Fellows’ academic experience over the last year.
Clifford Saper, the James Jackson Putnam Professor of Neurology at Harvard Medical School, recently received the 2012 Distinguished Scientist Award from the Sleep Research Society.
Established in 1989, the Distinguished Scientist award recognizes significant, original and sustained scientific contributions of a basic, clinical or theoretical nature to the sleep and circadian research fields.Saper's research explores the brain circuitry that controls basic functions, such as wake-sleep cycles and circadian rhythms, as well as cardiovascular and respiratory function. His laboratory has contributed to the understanding of the ascending arousal systems in the brain and the sleep promoting systems in the brain. It has also studied the different behavioral states, and the brainstem circuitry controlling autonomic and respiratory activity.
Michael Slama and Eduardo Hariton, Harvard Medical School students, recently received Paul and Daisy Soros Fellowships for New Americans. The purpose of the fellowship is to provide opportunities for continuing generations of able and accomplished new Americans to achieve leadership in their chosen fields.
Mount Auburn Hospital was named one of America’s "100 Best Hospitals" for cardiac surgery in 2012 by HealthGrades, an independent health care ratings company. HealthGrades used 12 years of Medicare data, 150 million patient hospitalization records, and 26 different diagnoses, procedures and conditions to rank the hospitals.
Frederick Alt, HMS Charles A. Janeway professor of pediatrics and genetics at Boston Children’s Hospital, was awarded the 2012 Arthur Kornberg and Paul Berg Lifetime Achievement Award in Biomedical Sciences from the Stanford University Medical Center Alumni Association. Alt was recognized for his discoveries of mechanisms that generate and suppress genomic instability in cancer cells and for his work on mechanisms that generate diverse antibody repertoires and their integration into lymphocyte development.
John Ayanian, HMS professor of medicine and health care policy, received the Society of General Internal Medicine (SGIM) 2012 John M. Eisenberg National Award for Career Achievement in Research. This award recognizes a senior SGIM member whose research has changed the way patients are cared for, research is conducted or students are educated. As a principal investigator, Ayanian has led research grants from the National Cancer Institute, Agency for Healthcare Research and Quality and major health care foundations.Ayanian is also a professor in the Department of Health Policy and Management at the Harvard School of Public Health.
Jeffrey Garber, HMS associate professor of medicine at Beth Israel Deaconess Medical Center and Brigham and Women’s Hospital, was named president of the American College of Endocrinology.Garber is the chief of endocrinology at Harvard Vanguard Medical Associates and a member of the Beth Israel’s and Brigham and Women’s endocrine divisions.
Nishan Goudsouzian, HMS professor of anaesthesia at Massachusetts General Hospital, received the Robert M. Smith award from the American Academy of Pediatrics as the foremost expert on muscle relaxants in children and for his outstanding contributions to the field of pediatric anesthesia.
R. Paul Johnson, HMS associate professor of Medicine at Massachusetts General Hospital, was named interim director of the New England Primate Research Center.
The website of the Wyss Institute for Biologically Inspired Engineering received the 2012 Webby Award in the science category from the International Academy of Digital Arts and Sciences. The Wyss Institute uses nature's design principles to develop bioinspired materials and devices that will transform medicine and create a more sustainable world.
Ryan Corcoran, HMS instructor of medicine, was awarded the Damon Runyon Cancer Research Award. Corcoran's goal is to develop new treatment strategies for BRAF mutant colorectal cancer. Mutations in the BRAF gene occur in 10-15% of colorectal cancers and predict poor outcome. Through a combination of laboratory studies and clinical trials, he plans to identify other key survival signals in BRAF mutant colorectal cancers that can be targeted, in combination with BRAF inhibitors, to improve treatment response in BRAF mutant colorectal cancer patients. Ultimately, he aims to develop novel effective treatments for patients with this lethal subtype of colorectal cancer. Corcoran works under the mentorship of Jeffrey Engelman, HMS associate professor of medicine, and Keith Flaherty, HMS associate professor of medicine at Massachusetts General Hospital.
Four researchers received 2012 Mass Eye and Ear Curing Kids Fund research grants, competitive grants awarded to researchers at Massachusetts Eye and Ear and Schepens Eye Research Institute for projects that aim to help the brain identify sound, discover genes that cause congenital blindness, treat deafness through hair cell regeneration and improve treatments for childhood eye cancer. The recipients are Bertrand Delgutte, HMS professor of otology and laryngology; Eric Pierce, HMS lecturer on ophthalmology; Fuxin Shi, HMS instructor in ostology and laryngology; Bruce Ksander, HMS associate professor of ophthalmology, and Dong Feng Chen, HMS associate professor of ophthalmology. The Fund also supports services that provide disadvantaged children with eyeglasses and hearing aids, and funds a Curing Kids endowment for key research to help children.
Joslin Diabetes Center, Beth Israel Deaconess Medical Center (BIDMC) and Boston Health Care for the Homeless were recently awarded an $11.6 million grant from the federal government to expand programs focused on keeping sick seniors out of hospitals, bettering the health of children with asthma, and connecting people who are homeless with improved medical care. The grants were announced by the Centers for Medicare and Medicaid Services and are among $123 million awarded under the Affordable Care Act to programs aimed at improving the quality of health care and lowering its costs. BIDMC will receive $4.9 million to build upon its already established pilot program to keep Medicare recipients who are discharged from the hospital from being readmitted again soon after. Joslin Diabetes Center received a grant for $5 million that will provide diabetes training in New Mexico, Pennsylvania and Washington, D.C., with the goal of serving 3,000 Medicare and Medicaid enrollees. The grant will also help to train community health workers in New England hospitals, including Boston Medical Center and Children’s Hospital Boston. These workers will go to the homes of children with severe and poorly managed asthma and help to address environmental problems such as mold, provide medication training and supply vacuums and other tools against asthma triggers.
Suffolk University will honor Augustus White, III, as an esteemed physician, educator and leader in the national fight for equality in health care. He will receive an honorary Doctor of Science degree at the Suffolk’s undergraduate commencement ceremony on Sunday, May 19.
White, the Ellen and Melvin Gordon Distinguished Professor of Medical Education and HMS professor of orthopedic surgery and at Beth Israel-Deaconess Medical Center, is a world-renowned specialist in care of the spine. In 1978, White was chosen to head the orthopedic surgery department at Boston’s Beth Israel Hospital, making him the first African American department chief in a major Harvard teaching hospital.
The Albert Schweitzer Fellowship recently announced the selection of its 2012-13 class of Boston Schweitzer Fellows—15 graduate students who will spend the next year learning to effectively address the social factors that impact health, developing lifelong leadership skills and living famed physician-humanitarian Albert Schweitzer’s message of service. Joining approximately 230 other 2012-13 Schweitzer Fellows at 12 program sites throughout the U.S., the newly selected Boston Schweitzer Fellows represent 7 universities, 15 academic programs and 8 health and human service disciplines. Fellows will partner with community-based organizations to develop and implement yearlong, mentored service projects that improve health and well-being in underserved communities—all on top of their regular graduate school responsibilities. The fellows from HSDM, HSPH and HMS are:
Sydnee Chavis,Harvard School of Dental Medicine
Chavis is raising awareness of special needs populations’ unique health issues by developing a new, multidisciplinary student group at Harvard Medical School. She will introduce a forum for medical and dental students to learn more about special needs health considerations, get involved in their communities and find encouragement to treat special needs populations within their patient bases in their future careers.
Stephanie Loo, Harvard School of Public Health
Loo is addressing gender disparities and socio-communal health in the Somali Bantu refugee community of Greater Boston by establishing a young women’s leadership empowerment group with Somali Bantu females of middle and high school ages. Her weekly program with these young women will provide peer tutoring and group mentoring opportunities and will incorporate social and cultural activities that promote and feature the Somali Bantu heritage and traditions—uniting and fostering a growing community of strong young women who will become the next leaders and role models for their community.
Raaj Mehta, Harvard Medical School
Mehta is addressing the practical and emotional implications of food allergies in low-income families by setting up a series of supportive and interactive educational workshops, support group sessions and cooking demonstrations. In addition to improving food allergy management skills and educating families about anaphylaxis, Mehta’s project seeks to reduce families’ anxiety associated with food allergies, increase awareness of allergy issues and identify safe and healthy eating options for all parties involved.
Janet Iwasa, HMS lecturer on Cell Biology, was listed by Fast Company magazine as one of 2012’s Most Creative People (http://www.fastcompany.com/most-creative-people/2012/janet-iwasa).
The “Most Creative People In Business” is an annual list of individuals from a wide array of industries. According to Fast Company, the list is a "celebration of business innovators who dare to think differently. They're the ones taking risks and discovering surprising new solutions to old problems." The list includes business leaders, academics, entrepreneur and entertainers.
David Nathan, the Robert A. Stranahan Distinguished Professor of Pediatrics and HMS professor of medicine at Dana-Farber Cancer Institute, president emeritus of the Dana-Farber Cancer Institute, and physician-in-chief emeritus at Children's Hospital Boston, received an honorary doctor of science degree at Clarkson University's 119th Commencement on May 12.
The degree was awarded for his role as a physician and medical research pioneer, whose advances in research have had a profound and lasting impact on the understanding and treatment of hematological diseases and cancer; and for “his role as an innovative administrator and an influential educator, under whose wisdom and guidance several generations of leading physicians have trained.”
Nathan’s research has focused on the inherited disorders of red cells and granulocytes and particularly on Thalassemia and sickle cell anemia. Over the course of his nearly 50-year career, his advances in medicine include the development of the first prenatal diagnostic test for thalassemia and sickle cell anemia, the introduction of effective treatment of iron overload and the only FDA approved drug for the amelioration of sickle cell anemia symptoms.
Cambridge Health Alliance (CHA) will honor national healthcare leader Donald Berwick, HMS lecturer on health care policy, on May 30 at CHA’s fifth annual Art of Healing Award dinner.
Berwick is the former president and CEO of the Institute for Healthcare Improvement (IHI), an organization that he co-founded and led for over 20 years. His work at IHI focused on identifying and testing new models of care in partnership with both patients and health care professionals, and ensuring the broadest possible adoption of best practices and effective innovations at hospitals across the country. In July 2010, President Obama appointed Berwick to the position of Administrator of the Centers for Medicare and Medicaid Services (CMS), a position he held until December 2011.
A pediatrician by background, Berwick has served on the staffs of Children’s Hospital Boston, Massachusetts General Hospital and Brigham and Women's Hospital. He is widely recognized as an inspirational teacher and mentor and has served on the faculty of Harvard Medical School and Harvard School of Public Health. He was vice chair of the U.S. Preventive Services Task Force, the first Independent Member of the Board of Trustees of the American Hospital Association and chair of the National Advisory Council of the Agency for Healthcare Research and Quality. An elected member of the Institute of Medicine (IOM), Berwick served two terms on the IOM’s governing Council and was a member of the IOM’s Global Health Board.
Berwick is internationally known for his commitment to patient-centered care and improving patient safety, tenets at the core of CHA’s mission.
Jack Szostak, HMS professor of genetics at Massachusetts General Hospital, and Atul Gawande, HMS associate professor of surgery at Brigham and Women’s Hospital and HSPH associate professor of health policy and management, are two of 35 new members recently elected to the American Philosophical Society (APS). Election to the APS honors extraordinary accomplishments in all fields. The APS is unusual among learned societies because its membership is comprised of top scholars from a wide variety of academic disciplines. As of the April 2012 elections the APS has 1022 members.
Sanjiv Chopra, HMS faculty dean for continuing education and professor of medicine at Beth Israel-Deaconess Medical Center, and Nishan Goudsouzian, HMS professor of anaesthesia at Massachusetts General Hospital, were recently awarded Ellis Island Medals of Honor by the National Ethnic Coalition (NECO).
NECO supports new education initiatives and medical research endeavors, partners with humanitarian organizations nationally and internationally, celebrates the diversity, achievements and progress of all ethnic backgrounds and promotes tolerance and cultural awareness. The Ellis Island Medals of Honor are awarded annually to a group of distinguished living U.S. citizens who exemplify the highest American ideals, including dedication to community service, preservation of the values of his or her ancestry group(s), and distinguished service to humanity in any field, profession, or occupation.
Cambridge Health Alliance(CHA) recently received an Institutional Partner Award from the Medical Advisory Committee for the Elimination of Tuberculosis (MACET). CHA was one of two institutions honored statewide for extraordinary contributions to protect their communities at an award ceremony and legislative briefing at the Massachusetts State House for World No TB Day 2012. On average, patients with TB disease or TB infection from Cambridge and surrounding communities make over 2,000 visits annually to CHA for treatment and care, with prevention, education and case management led by the Cambridge Public Health Department, which is part of CHA. Last year, the Cambridge program fully integrated TB patient medical records into CHA’s electronic medical records system, making it the first state-partnered TB clinic in the Commonwealth to do so. In selecting CHA for this year’s award, the MACET noted CHA’s innovative use of electronic medical records as well as the system’s consistent focus on the synergies and partnership between public health and medical providers.
Alan D’Andrea, the Alvan T. and Viola D. Fuller American Cancer Society professor of radiation oncology at Harvard Medical School and the Dana-Farber Cancer Institute, recently received the 52nd Annual American Association for Cancer Research G.H.A. Clowes Memorial Award for his work in understanding cancer survival and progression, which has included milestones such as cloning the erythropoietin receptor and discovering the Fanconi anemia family of proteins involved in maintaining DNA stability. Work from his laboratory has shown that the study of rare pediatric cancer susceptibility syndromes, such as Fanconi anemia, can lead to broad insights into the cause and treatment of cancer in the general population.
The AACR and Eli Lilly and Company established the G.H.A. Clowes Memorial Award in 1961 to honor G.H.A. Clowes, a founding member of the AACR. This honor recognizes an individual with outstanding recent accomplishments in basic cancer research. D’Andrea delivered a lecture, “Targeting DNA Repair in Cancer Therapy: Lessons From Fanconi Anemia,” at the AACR Annual Meeting 2012 in April.
D’Andrea is professor of radiation oncology at Dana Farber, of genetics and complex diseases at Harvard School of Public Health, and is co-director of the Gene Therapy Center at Children’s Hospital of Boston, where he is also professor of pediatrics.
Rajni Aneja, was recently named executive vice president of Joslin Diabetes Center.
Aneja will work across all areas of Joslin to address Joslin’s numerous local, national, and global initiatives. She will be actively involved with Joslin’s partners and collaborators to create and deliver cost-effective and high impact diabetes solutions within today’s healthcare economic environment.
Prior to coming to Joslin, Aneja was Chief Medical officer for WebMD health services, and in the past has held roles as the National Medical Director for Disease Management, Quality and Standards for OptumHealth, a UnitedHealth Group company. She has been extensively involved in industry efforts to address the fundamental drivers of utilization and the quality of healthcare service delivery. She is an active contributing member of the Care Continuum Alliance (formerly the Disease Management Association of America), as well as the American College of Physician Executives.
Aneja is a certified physician executive with specialty training in family practice. She earned her medical degree from Research Medical Center in Kansas City, Missouri, and her physician executive M.B.A. from the University of Massachusetts.
Michael Hamblin, HMS associate professor of dermatology at Massachusetts General Hospital and member of the affiliated faculty of the Harvard-MIT Division of Health Sciences and Technology, was recently named a fellow to the International Society for Optics and Photonics (SPIE) for his achievements in laser photomedicine.
Hamblin is a leading researcher in the areas of photodynamic therapy (PDT) for treatment of cancer and infections, fluorescence diagnosis of diseases, and low-level light therapy. He was one of the first to study PDT-induced immunological responses in cancer treatment, which is a promising avenue for fighting metastatic cancers. Hamblin also designed and prepared a versatile new class of antimicrobial and anticancer photosensitizer-conjugates, and demonstrated their efficacy in vitro and in vivo for new animal models of infection. His cutting-edge work in low-level light therapy (LLLT) includes discovering many basic mechanisms of action of LLLT at a cellular and molecular level and its application to disease and injuries.
SPIE honored 75 new Fellows of the Society this year. Fellows are members of distinction who have made significant scientific and technical contributions in the multidisciplinary fields of optics, photonics and imaging.
Rakesh Jain, A. Werk Cook Professor of Radiation Oncology (Tumor Biology) at Harvard Medical School and director of E.L. Steele Laboratory of Tumor Biology at the Massachusetts General Hospital Cancer Center, is the recipient of the 2012 Science of Oncology Award and Lecture from the American Society of Clinical Oncology (ASCO). By combining his extensive expertise and experience in engineering, mathematics, tumor biology and physiology, Jain has created a novel approach to imaging technologies in cancer research that has provided unprecedented molecular, cellular, anatomical and functional insights into tumor barriers and how to overcome them. His discoveries have fundamentally changed the thinking of scientists and clinicians about how antiangiogenic agents work in people with cancer. Jain’s research also represents a premier example of bench-to-bedside translation in oncology.
Each year through its Special Awards Program, ASCO recognizes researchers, patient advocates and leaders of the global oncology community who, through their work, have made significant contributions to enhancing cancer care. These recipients of ASCO’s highest, most prestigious awards collectively represent significant strides in cancer treatment and leadership in the oncology community.